Fatigue and anorexia, the aetiology of which is not understood, are often dose-limiting with chronic administration for cancer or MS; at higher doses weight loss occurs and may be significant (>10%).
1
—
—
Fatigue and anorexia, the aetiology of which is not understood, are often dose-limiting with chronic administration for cancer or MS; at higher doses weight loss occurs and may be significant (>10%).